Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Hauschild
Peter Mohr

Showing results (1-10 of 489) with videos related to

Pageof 49
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Axel Hauschild, Peter Mohr
Oncology Research and Treatment|May 14, 2015
[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy]Axel Hauschild, Peter Mohr
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Acta Dermato-Venereologica|May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate DehydrogenaseValerie Glutsch, Teresa Amaral, Claus Garbe, et al.
Oncology Research and Treatment|October 26, 2016
[Immunonkologie beim malignen Melanom: Von der Monotherapie zur Kombinationstherapie - aktuelle Studiendaten und Fragestellungen]Axel Hauschild
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Could controlling occult cytomegalovirus reactivation with prophylactic valganciclovir prevent immune checkpoint blockade-Related complications?Axel Hauschild
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2007
[Clinical studies with sorafenib (Nexavar) in metastatic melanoma]Axel Hauschild
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 11, 2014
[Working Group on Dermatological Oncology]Axel Hauschild
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 14, 2005
[Sentinel lymph node biopsy]Axel Hauschild
Melanoma Research|February 6, 2003
Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trialKarsten Neuber, Uwe Reinhold, Andrea Deutschmann, et al.
Pageof 49

Showing results (1-10 of 489) with videos related to

Sort By:
Pageof 49
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Axel Hauschild, Peter Mohr
Oncology Research and Treatment|May 14, 2015
[Rationale, visions and limits of Immuno-oncology: Checkpoint inhibition as a new pillar of tumor therapy]Axel Hauschild, Peter Mohr
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanomaPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Acta Dermato-Venereologica|May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate DehydrogenaseValerie Glutsch, Teresa Amaral, Claus Garbe, et al.
Oncology Research and Treatment|October 26, 2016
[Immunonkologie beim malignen Melanom: Von der Monotherapie zur Kombinationstherapie - aktuelle Studiendaten und Fragestellungen]Axel Hauschild
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Could controlling occult cytomegalovirus reactivation with prophylactic valganciclovir prevent immune checkpoint blockade-Related complications?Axel Hauschild
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2007
[Clinical studies with sorafenib (Nexavar) in metastatic melanoma]Axel Hauschild
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 11, 2014
[Working Group on Dermatological Oncology]Axel Hauschild
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 14, 2005
[Sentinel lymph node biopsy]Axel Hauschild
Melanoma Research|February 6, 2003
Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trialKarsten Neuber, Uwe Reinhold, Andrea Deutschmann, et al.
Pageof 49